CUMTAS

Customized Micro Total Analysis Systems to Study Human Phase I Metabolism

 Coordinatore HELSINGIN YLIOPISTO 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Finland [FI]
 Totale costo 1˙499˙668 €
 EC contributo 1˙499˙668 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2012-StG_20111109
 Funding Scheme ERC-SG
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-05-01   -   2018-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    HELSINGIN YLIOPISTO

 Organization address address: YLIOPISTONKATU 4
city: HELSINGIN YLIOPISTO
postcode: 14

contact info
Titolo: Dr.
Nome: Kaisu
Cognome: Taskila
Email: send email
Telefono: +3589191 58909

FI (HELSINGIN YLIOPISTO) hostInstitution 1˙499˙668.00
2    HELSINGIN YLIOPISTO

 Organization address address: YLIOPISTONKATU 4
city: HELSINGIN YLIOPISTO
postcode: 14

contact info
Titolo: Dr.
Nome: Tiina Marjukka
Cognome: Sikanen
Email: send email
Telefono: 358505000000
Fax: 358919000000

FI (HELSINGIN YLIOPISTO) hostInstitution 1˙499˙668.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

microfluidic    analytical    reaction    chip    chemicals    pharmaceuticals    microfabrication    metabolic    chemical    techniques    instrumentation    metabolism   

 Obiettivo del progetto (Objective)

'The goal of this project is to develop inexpensive, high-throughput technology to screen the thus far unexplored metabolic interactions between environmental and household chemicals and clinically relevant drugs. The main influential focus will be on human phase I metabolism (redox reactions) of common toxicants like agrochemicals and plasticizers. On the basis of their structural resemblance to pharmaceuticals and endogenous compounds, many of these chemicals are suspected to have critical effects on cytochrome P450 metabolism which is the main detoxification route of pharmaceuticals in man. However, with the current analytical instrumentation, screening of such large chemical pool would take several years, and new chemicals would be introduced faster than the old ones are screened. Thus, the main technological goal of this project is to develop novel, practically zero-cost analytical instruments that enable characterization of a compound’s metabolic profile at very high speed (<1 min/sample). This goal is achieved through miniaturization and high degree of integration of analytical instrumentation by microfabrication means, an approach often called lab(oratory)-on-a-chip. The microfabricated arrays are envisioned to incorporate all analytical key functions required (i.e., sample pretreatment, metabolic reaction, separation of the reaction products, detection) on a single chip. Thanks to the reduced dimensions, the amount of chemical waste and consumption of expensive reagents are significantly reduced. In this project, several different microfabrication techniques, from delicate cleanroom processes to extremely simple printing techniques, will be exploited to produce smart microfluidic designs and multifunctional surfaces. Towards the end of the project, more focus will be put on “printable microfluidics” which provides a truly low-cost approach for fabrication of highly customized microfluidic assays. Numerical modelling is also an integral part of the work.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

GAUGEGRAVSYM (2014)

Extended Symmetries in Gauge and Gravity Theories

Read More  

MORPHOSTASIS (2009)

Morphostasis of the intestinal mucosa and it's deregulation in cancer and inflammation

Read More  

EMPSI (2014)

"Receptors, Channels and Transporters: Development and Application of Novel Technologies for Structure Determination"

Read More